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Abstract
Purpose High-fructose consumption and chronic stress are both associated with metabolic inflammation and insulin resist-
ance. Recently, disturbed activity of energy sensor AMP-activated protein kinase (AMPK) was recognized as mediator 
between nutrient-induced stress and inflammation. Thus, we analyzed the effects of high-fructose diet, alone or in combina-
tion with chronic stress, on glucose homeostasis, inflammation and expression of energy sensing proteins in the rat liver.
Methods In male Wistar rats exposed to 9-week 20% fructose diet and/or 4-week chronic unpredictable stress we measured 
plasma and hepatic corticosterone level, indicators of glucose homeostasis and lipid metabolism, hepatic inflammation 
(pro- and anti-inflammatory cytokine levels, Toll-like receptor 4, NLRP3, activation of NFκB, JNK and ERK pathways) 
and levels of energy-sensing proteins AMPK, SIRT1 and peroxisome proliferator-activated receptor gamma coactivator-1 
alpha (PGC-1α).
Results High-fructose diet led to glucose intolerance, activation of NFκB and JNK pathways and increased intrahepatic 
IL-1β, TNFα and inhibitory phosphorylation of insulin receptor substrate 1 on  Ser307. It also decreased phospho-AMPK/
AMPK ratio and increased SIRT1 expression. Stress alone increased plasma and hepatic corticosterone but did not influence 
glucose tolerance, nor hepatic inflammatory or energy-sensing proteins. After the combined treatment, hepatic corticosterone 
was increased, glucose tolerance remained preserved, while hepatic inflammation was partially prevented despite decreased 
AMPK activity.
Conclusion High-fructose diet resulted in glucose intolerance, hepatic inflammation, decreased AMPK activity and reduced 
insulin sensitivity. Chronic stress alone did not exert such effects, but when applied together with high-fructose diet it could 
partially prevent fructose-induced inflammation, presumably due to increased hepatic glucocorticoids.
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Introduction
Modern way of living, which combines consumption of 
energy-dense foods and psychosocial stress, is associ-
ated with health threats, such as metabolic syndrome, 
cardiovascular diseases and cancer. Fructose-fed rat is 
a model reproducing various aspects of metabolic syn-
drome, including hypertriglyceridemia, insulin resistance 
and hepatic steatosis [1]. Moreover, stress increases vis-
ceral adiposity and weight gain by changing eating pat-
terns and shifting preference towards palatable foods high 
in fat and sugar [2]. However, the relationship between 
stress and obesity remains elusive, as some people lose 
weight when exposed to stress [3]. Both fructose- and 
stress-mediated metabolic disturbances are associated with 
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low-grade chronic inflammation, characterized by activa-
tion of proinflammatory nuclear factor kappa B (NFκB), 
c-Jun N-terminal kinase 1 (JNK) and extracellular signal-
regulated kinase (ERK) signaling pathways and increased 
production of proinflammatory cytokines (tumor necrosis 
factor α (TNFα), interleukin (IL) 1β and IL-6) [4]. Inflam-
matory response may in turn impair insulin signaling by 
increasing inhibitory phosphorylation of insulin receptor 
substrate 1 (IRS1) on serine residues [5]. Indeed, JNK 
phosphorylates IRS1 on  Ser307 residue, which represents 
an early hallmark of tissue insulin resistance [6], while 
ERK promotes insulin resistance through phosphorylation 
of IRS1 on  Ser612 [7].
AMP-activated protein kinase (AMPK), one of the prin-
cipal cellular energy sensors, plays an important role in 
maintaining energy homeostasis through downregulation 
of ATP-consuming pathways and stimulation of ATP-pro-
ducing pathways [8]. Impairment of hepatic AMPK activity 
is a key pathological event in the development of the insulin 
resistance and hepatic steatosis in the metabolic syndrome 
[9]. However, the new emerging role of AMPK signaling is 
in the regulation of metabolic inflammation [10]. Studies in 
both humans and experimental animals showed a negative 
association between diet-induced inflammation and AMPK 
activity [9]. Moreover, high-fat or high-fructose diet acti-
vates inflammation by suppressing AMPK pathway in the 
heart [11, 12]. In addition, glucocorticoid-induced changes 
in AMPK constitute a novel mechanism that could explain 
the deposition of lipids in visceral adipose and hepatic 
tissue.
Multiple studies have demonstrated that AMPK restrains 
inflammation through inhibition of NFκB, a key regulator of 
innate immunity and inflammation [13, 14]. In unstimulated 
cells, NFκB is sequestered in the cytoplasm in an inactive 
complex with inhibitory protein κB (IκB) and is activated by 
phosphorylation and degradation of IκB [15]. Since AMPK 
activity is decreased in obesity and metabolic syndrome, 
this could lead to derepression of proinflammatory stimuli 
associated with diet/obesity and appearance of a low-grade 
metabolic inflammation [16]. Inhibitory effects of AMPK 
on NFκB signaling are likely to be indirect and governed by 
downstream mediators, such as sirtuin 1 (SIRT1) and per-
oxisome proliferator-activated receptor gamma coactivator 1 
alpha (PGC-1α) [16]. Indeed, SIRT1 deacetylates the RelA/
p65 subunit of NFκB complex that triggers the ubiquitina-
tion and degradation of NFκB [17]. Increased activity of 
PGC-1α could inhibit NFκB activity and proinflammatory 
response induced by TNFα in vascular cells [18]. High-
fructose ingestion has been described to reduce [19] or to 
increase SIRT1 and PGC-1α activities [20], and the effect 
of stress on SIRT1 activity is also still controversial [21]. 
Therefore, the dysregulation of energy sensing may link 
nutrient metabolism to inflammation and insulin resistance.
Only few studies have focused on the mechanisms under-
lying metabolic inflammation provoked by the interaction 
between a carbohydrate-enriched diet and stress [22, 23]. 
The aim of this study was to investigate the effects of high-
fructose diet and chronic unpredictable stress, separately or 
in combination, on glucose homeostasis and hepatic inflam-
mation in the male Wistar rats, as well as to reveal whether 
these metabolic perturbations are linked with the alterations 
in energy-sensing proteins levels. The concentration of 20% 
fructose solution was chosen to resemble the consump-
tion of fructose-sweetened beverages in human population 
[24], while chronic unpredictable stress protocol represents 
paradigm for everyday stress exposure in human life and 
consisted of psychological and physical stressors [25]. We 
examined the effect of fructose-enriched diet and/or chronic 
stress on the liver histology, the plasma and hepatic cor-
ticosterone level, parameters of glucose homeostasis (glu-
cose tolerance, fasting glucose and insulin plasma values, 
phosphoenolpyruvate carboxykinase (PEPCK) mRNA and 
phosphorylation of IRS1 at  Ser307) and lipid metabolism 
(plasma and hepatic triglyceride level and hepatic fatty acid 
composition). Hepatic inflammation was characterized by 
measuring the tissue level of pro- and anti-inflammatory 
cytokines, as well as by analyzing expression of proinflam-
matory factor NFκB and kinases JNK and ERK, Toll-like 
receptor-4 (TRL4) and Nod-like receptor protein 3 (NLRP3). 
In addition, the expression of main energy-sensing proteins 
AMPK, SIRT1 and PGC-1α were examined in the liver of 
rats exposed to high dietary fructose, alone or in combina-
tion with stress.
Materials and methods
Animals and treatment
Experiments were conducted on 2.5-month-old Wistar 
male rats, bred in our laboratory. At the beginning of the 
9-week experiment, rats were divided into four groups 
(n = 9 per group) and housed three per cage. Untreated 
control group (C) had free access to a standard chow 
diet (commercial food—Veterinary Institute, Subotica, 
Serbia) and drinking water [26]. The fructose-fed group 
(F) received high-fructose diet (20% fructose in drink-
ing water, API-PEK, Bečej, Serbia) and commercial food. 
The third, stress (S) group of animals was subjected to a 
modified version of the chronic unpredictable stress (CUS) 
protocol of Joels et al. [25] during the last 4 weeks of the 
treatment. The animals were successively exposed to one 
of the following daily stressors: forced swimming in cold 
water for 10 min, physical restraint for 30 min, cold room 
(4 °C) for 50 min, wet bedding for 4 h, rocking cages for 
1 h and cage tilt (45°) overnight. The time and type of 
European Journal of Nutrition 
1 3
daily stressors were randomly selected at the beginning 
of the treatment. The fourth group (SF) was exposed to 
both 9-week high-fructose diet and 4-week stress proto-
col. Free access to food was allowed to all the animals. 
Daily food and fluid intake were measured throughout the 
treatment, while body weight was recorded weekly. Total 
energy intake was expressed as kJ per day per animal and 
was calculated as previously reported [27]. The animals 
were maintained under a 12-h light–dark cycle (lights on 
at 7:00 a.m.) at 22 °C and constant humidity. The protocols 
were performed in compliance with Directive 2010/63/
EU on the protection of animals used for experimental 
and other scientific purposes and were approved by the 
Ethical Committee for the Use of Laboratory Animals of 
the Institute for Biological Research “Siniša Stanković”, 
University of Belgrade (reference number 3-12/12).
Blood plasma preparation, tissue collection, 
and determination of biochemical parameters
After an overnight fast, animals were killed at light onset 
(7:00 AM) by decapitation with a guillotine (Harvard Appa-
ratus, USA). Trunk blood was rapidly collected and the 
concentrations of glucose were measured by a  MultiCare® 
glucometer, using MultiCare Glucose strips (Biochemical 
Systems International, Italia), while triglyceride concen-
trations in the blood were measured by MultiCare Triglyc-
erides strips (Biochemical Systems International, Italia). 
Plasma was isolated by centrifugation at 1600×g for 10 min 
at 4 °C and then stored at − 20 °C. The concentration of 
plasma insulin was determined by the RIA method, using 
rat insulin standards (INEP, Serbia). Assay sensitivity was 
0.6 mIU/L and the intra-assay coefficient of variation was 
5.24%. Corticosterone was measured in the plasma and liver 
cytoplasmic extracts using the Corticosterone EIA kits (AC-
14F1 and AC-15F1, Immunodiagnostic Systems Ltd, UK, 
respectively) according to the manufacturer’s instructions. 
Absorbance at 450 nm (reference 650 nm) was measured 
spectrophotometrically (Multiskan Spectrum, Thermo, Fin-
land). Corticosterone concentrations were determined using 
four parameter logistic (4PL) curve-fitting method (Prism, 
GraphPad Software) and given as ng/ml or ng/mg of protein. 
The assay sensitivity was 0.17 ng/mL, while intra-assay and 
inter-assay CVs were 5.9 and 8.9%, respectively. To validate 
the use of cytoplasmic extracts in the ELISA, a spike and 
recovery experiment was done with the known amount of 
the kit standard. A dilution series was performed comparing 
the spiked vs. the unspiked sample and the obtained recovery 
range was between 87 and 113%.
After blood collection, the livers were perfused with cold 
0.9% NaCl, carefully excised and frozen in liquid nitrogen. 
Tissues were kept in liquid nitrogen for protein isolation.
Histological analysis of the liver
Samples of liver tissue were fixed in 4% paraformaldehyde 
for 24 h, dehydrated in an ethanol gradient, cleared in xylene 
and embedded in paraffin. Tissue blocks were sectioned at 
5 µm thickness and stained with hematoxylin and eosin. 
Microscopic analysis was carried out using a workstation 
comprising a microscope Leica DM RB Photo Microscope 
(Leica, Wetzlar, Germany) equipped with the Leica DFC320 
digital camera (Leica, Wetzlar, Germany).
Determination of hepatic triglycerides and fatty 
acid profile of total plasma and hepatic lipids
Liver triglycerides were isolated from 100 mg of liver tis-
sue using a modified Folch method [28] and analyzed with 
Triglycerides Reagent (Code 12528, Biosystem) on the 
semi-automatic biochemistry analyzer Rayto 1904-C (Rayto, 
China).
For analysis of fatty acid profile, total plasma lipids were 
extracted by the method of Glaser et al. [29], while total 
hepatic lipid extracts were isolated from ~ 500 mg liver tis-
sue by the method of Petrovic et al. [30]. Fatty acid com-
position of total lipids from plasma and liver was analyzed 
according to the protocol described by Petrovic et al. [30]. 
Individual fatty acid methyl esters in the samples were iden-
tified by comparing sample peak retention times with poly-
unsaturated fatty acid (PUFA)-2 standard mixture (Restek 
Co, Bellefonte, PA, USA). Fatty acid profiles were expressed 
as the percentage areas of total fatty acids. The Δ9 desatu-
rase activity was estimated as the product-to-precursor ratio 
of 18:1/18:0 [30].
Estimation of glucose tolerance
Intraperitoneal glucose tolerance test (IPGTT) was per-
formed 3 days before the end of the treatment. Food was 
removed the night before and fructose solution was tempo-
rarily replaced with water. A bolus of glucose was injected 
intraperitoneally (2 g/kg). Blood was obtained from the tail, 
and the glucose level was measured at 0, 30, 60, 90 and 
120 min after injection. The area under the glycemic curve 
over the course of the experiment (AUC glucose 0–120 min, 
mmol/L vs. min) was calculated by the trapezoidal rule.
Preparation of cytoplasmic, nuclear and whole cell 
extracts
Frozen livers were weighed and homogenized with 
Janke–Kunkel ultraturrax (30 s/30 s pause/30 s) in 4 vol. 
(w/v) of ice-cold homogenization buffer (20 mM Tris–HCl, 
pH 7.2, 10% glycerol, 50 mM NaCl, 1 mM EDTA-Na2, 
1 mM EGTA-Na2, 2 mM DTT, protease and phosphatase 
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inhibitors). The homogenates were filtered through gauze 
and centrifuged (2000×g, 15 min, 4  °C). The resulting 
supernatants were further processed to generate cytoplas-
mic fraction, while the pellets were used to obtain nuclear 
extracts, as previously published [27]. All steps were con-
ducted at 4 °C and all samples were aliquoted and stored at 
− 70 °C.
For preparation of whole cell extracts, tissues were 
homogenized with a glass–Teflon homogenizer in 5 vol. 
(w/v) of ice-cold RIPA buffer (50 mM Tris–HCl, pH 7.2, 
1 mM EDTA-Na2, 150 mM NaCl, 0.1% SDS, 1% Nonidet 
P-40, 0.5% sodium deoxycholate, 2 mM DTT, protease and 
phosphatase inhibitors) and homogenates were sonicated 
(3 × 5 s, 1 A, 50/60 Hz). After 60 min of incubation on ice 
with continuous agitation and frequent vortexing, suspen-
sions were centrifuged (16,000×g, 20 min, 4 °C) and the 
resulting supernatants were aliquoted, stored at − 70 °C and 
used as whole cell extracts.
Protein content of all cellular fractions was determined 
by the method of Spector [31] using bovine serum albumin 
as a standard.
Cytokine immunoassays
Levels of cytokines in the liver were determined by specific 
ELISA kit assay (Rat TNFα ELISA kit, # 88-7340-88, eBio-
science; rat IL-1β ELISA kit, DY501; rat IL-6 ELISA kit, 
DY506; rat IL-4 ELISA kit, DY504; rat IL-10 ELISA kit, 
DY522, all from R&D Systems) [32]. Cytokine measure-
ment was done in whole cell extracts from the livers iso-
lated by previously published protocol [33]. In brief, 100 mg 
of liver was homogenized in 10 vol. (w/v) of PBS buffer 
(137 mM NaCl, 2.7 mM KCl, 10 mM  Na2HPO4, 1.8 mM 
 KH2PO4, 0.5% Triton X-100 and protease inhibitors), then 
sonicated 3 × 5 s/30 s pause (30 Hz, pulse 0.5). Homogenates 
were centrifuged at 12,000×g, 10 min, 4 °C, and the result-
ing supernatants were aliquoted and stored at − 70 °C. The 
level of cytokines was measured in 96-well plates according 
to the manufacturer’s instructions. Absorbance was read at 
450 and 540 nm on the Multiskan Spectrum (Thermo Elec-
tron Corporation, Finland). Results were expressed as pg/
mg of protein.
Western blot analysis
After the samples were boiled in Laemmli’s buffer, 40 µg of 
cytosolic or whole cell extract, or 60 µg of nuclear extract 
proteins was resolved on 7.5 or 10% SDS-polyacrylamide 
gels. The samples intended to be compared were always 
run on the same gel. Separated proteins were transferred 
to PVDF membranes (Immobilon-FL, Millipore). The blots 
were blocked by PBS containing 2% non-fat dry milk for 
1 h at room temperature. After extensive washing (PBS 
containing 0.1% Tween 20), membranes were incubated 
overnight at 4 °C with the following anti-rabbit polyclonal 
antibodies: NFκB (p65 subunit) antibody (sc-372, 1:250), 
IκBα antibody (sc-371, 1:250), AMPKα 1/2 (sc-25792, 
1:500), SIRT1 antibody (sc-15404, 1:250), JNK1/2 (sc-571, 
1:500), all from Santa Cruz Biotechnology. Phospho-IκBα 
antibody  (Ser32) (#2859, 1:1000), phospho-AMPK  (Thr172) 
(#41885, 1:500), phospho-ERK1/2  (Thr202/Tyr204) (#9101, 
1:250), ERK1/2 (#9102, 1:1000), phospho-JNK1/2  (Thr183/
Tyr185) (#9251S, 1:250) were all from Cell Signaling, while 
PGC-1α (ab54481, 1:1000), NLRP3 (ab214185, 1:500) and 
phospho-IRS1  (Ser307) antibodies (ab5599, 1:1000) were 
from Abcam. Anti-β-actin (ab-8227, Abcam, 1:10,000) and 
TATA box-binding protein (TBP, ab-22595, Abcam, 1:1000) 
were used as an equal loading control for cytosolic/whole 
cell and nuclear protein, respectively. Membranes were sub-
sequently washed and incubated for 90 min with horseradish 
peroxidase-conjugated secondary antibodies (Thermo Scien-
tific, 1:5000). The immunoreactive proteins were visualized 
by chemiluminescent (ECL) method and quantitative analy-
sis was performed by ImageJ software (National Institute of 
Health, USA).
RNA isolation and reverse transcription
Total RNA was isolated from liver tissue using  TRIzol® 
Reagent (AmBion, Life Technologies, Carlsbad, CA, USA) 
according to the manufacturer’s instructions. Quantitative 
and qualitative evaluation of the isolated RNA was per-
formed spectrophotometrically (OD 260/280 > 1.8 was con-
sidered satisfactory) and on 2% agarose gel. Prior to cDNA 
synthesis, DNA contamination was removed by DNAse I 
treatment (Fermentas, Burlington, ON, Canada). Reverse 
transcription was performed using a high-capacity cDNA 
Reverse Transcription Kit (Applied Biosystems, Foster City, 
CA, USA) according to the manufacturer’s instructions. The 
cDNAs were stored at − 70 °C until use.
Real‑time PCR
Quantification of glucocorticoid receptor (GR) and PEPCK 
gene expression in the liver was performed by  TaqMan® 
real-time polymerase chain reaction (PCR). The follow-
ing probe sets were used: GR (Rn00561369_m1*) and 
PEPCK (Rn01529014_m1*), all obtained from Applied 
Biosystems Assay-on Demand Gene Expression Products. 
β-Actin (Rn00667869_m1*) was used as internal control 
for quantitative normalization of cDNA. Real-time PCR 
was performed using the QuantStudio™ Real-Time PCR 
Systems as previously described [26]. The expression of 
TLR4 and AMPK genes was analyzed using Power  SYBR® 
Green PCR Master Mix (Applied Biosystems) and specific 
primers (Metabion): TLR4 forward 5′-ATC ATC CAG GAA 
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GGC TTC CA-3′, reverse 5′-GCT AAG AAG GCG ATA 
CAA TTC-3′ and AMPKα1 forward 5′-GGG ATC CAT 
CAG CAA CTA TCG-3′, reverse 5′-TTC CTG GTC TTG 
GAG CTA CGT-3′. Quantitative normalization of cDNA in 
each sample was performed using β-actin (forward 5′-CCC 
TGG CTC CTA GCA CCA T-3′, reverse 5′-GAG CCA CCA 
ATC CAC ACA GA-3′) as endogenous control. Real-time 
PCR was performed using QuantStudio™ Real-Time PCR 
Systems (Applied Biosystems, Foster City, CA, USA) as 
previously published [26]. Relative quantification of gene 
expression was examined using comparative 2−ΔΔCt method 
described by Livak and Schmittgen [34]. The results were 
analyzed by QuantStudio™ Design and Analysis v1.3.1 
(Applied Biosystems, Foster City, CA, USA) with a confi-
dence level of 95% (p ≤ 0.05).
Statistical analysis
The data for physiological, biochemical and insulin sensitiv-
ity parameters, as well as ELISA, Western blot and real-time 
PCR data were given as means ± SEM. The normality of the 
data was analyzed by Shapiro–Wilk test. Two-way ANOVA 
followed by Tukey post hoc test was used to evaluate the 
effects of fructose diet and stress, as well as their interac-
tion on treated groups. Results were considered statistically 
significant at p < 0.05. Statistical analyses were performed 
by STATISTICA 8.0. software (StatSoft, Inc., USA).
Results
Effects of high‑fructose diet and/or stress on energy 
intake, body composition and corticosterone level 
in male Wistar rats
Fructose diet caused a significantly higher total energy 
intake (37−44%) in both fructose and fructose + stress 
groups, as compared to untreated controls or rats exposed 
only to stress (Table 1, p < 0.001 for all comparisons). 
However, the increase in caloric intake was not translated 
into significant increase of either body weight or liver 
mass in fructose-fed rats, with the exception of a 26% 
increase in the liver-to-body weight ratio in the fructose-
only group compared to controls (Table 1, p < 0.05, F vs. 
C).
As expected, a significant increase of plasma corticos-
terone level was detected in stressed animals on stand-
ard diet in comparison to the control animals (Table 1, 
p < 0.01, S vs. C), while it was not changed in the liver of 
fructose-fed stressed animals. The stress treatment also 
increased intracellular corticosterone level by 45% in the 
liver of both groups exposed to stress in comparison to 
untreated control rats (Table 1, p < 0.05, S vs. C; SF vs. 
C). The increase of stress hormone is not related to altered 
GR gene expression since GR mRNA was not changed in 
any of the examined group (Fig. 1).
Table 1  The effects of high-fructose diet and chronic stress on physiological and biochemical parameters in male Wistar rats
Cumulated caloric intake, body and liver mass, blood glucose, plasma insulin and corticosterone (CORT), quantification of the glycemic excur-
sion during the IPGTT (AUC) and liver corticosterone level were measured after 9 weeks on high-fructose diet and 4 weeks of chronic unpre-
dictable stress in male Wistar rats
All data are presented as means ± SEM (n = 8–9). Comparisons between groups were made by two-way ANOVA followed by post hoc Tukey 
test. Different symbols denote the values that are significantly different from control group (*p < 0.05, **p < 0.01, ***p < 0.001) and fructose-fed 
group ($p < 0.05)
NS non-significant
Control Fructose Stress Fructose + stress Two-way ANOVA
Fructose Stress Fructose × stress
Caloric intake (kJ/day/animal) 182.01 ± 3.46 261.99 ± 9.98*** 175.68 ± 4.46 248.68 ± 9.04*** < 0.001 NS NS
Body mass (g) 369 ± 6.25 330 ± 14.78 338 ± 13.11 338 ± 15.25 NS NS NS
Mass of liver (g) 15.45 ± 0.72 16.99 ± 0.81 14.58 ± 0.80 16.86 ± 1.20 NS NS NS
Liver/body ratio (× 1000) 41.81 ± 1.79 52.17 ± 1.21* 43.05 ± 1.35 50.95 ± 4.72 < 0.01 NS NS
Plasma CORT (ng/mL) 168.42±36.13 196.2 ± 55.8 523.59±108** 249.67±52.57 NS < 0.01 NS
Liver CORT (ng/mg) 0.33 ± 0.04 0.38 ± 0.03 0.48 ± 0.03* 0.48 ± 0.04* NS < 0.01 NS
Glucose (mmol/L) 4.54 ± 0.13 4.03 ± 0.14* 4.18 ± 0.14 3.92 ± 0.13** < 0.01 NS NS
Insulin (mIU/L) 10.07 ± 1.85 19.44 ± 2.45* 10.62 ± 1.87 20.84 ± 3.40** < 0.001 NS NS
IPGTT (AUC glucose level) 960.40 ± 26.95 1635.00 ± 206.30** 1094.20 ± 153.90 1010.20 ± 51.14$ < 0.05 NS < 0.01
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High‑fructose diet promotes metabolic 
dysregulation
Fructose treatment led to a ~ twofold increase of plasma 
insulin and a decrease of fasting plasma glucose (by 
11–13%) in both fructose and fructose + stress groups 
(Table  1, p < 0.05, F vs. C; p < 0.01, SF vs. C). The 
observed hypoglycemia is in accordance with decreased 
PEPCK mRNA level in both fructose-fed groups (Fig. 1, 
p < 0.05, F vs. C; SF vs. C). The glycemic excursion dur-
ing the IPGTT was significantly higher in the fructose-fed 
group compared to untreated controls, as measured by glu-
cose peak level (Fig. 2a, p < 0.05, F vs. C) and area under 
the curve (AUC: Table 1, p < 0.01, F vs. C), indicating 
glucose intolerance. Strikingly, the stress treatment pre-
vented the development of fructose-induced glucose intol-
erance in fructose + stress rats (Table 1, p < 0.05, SF vs. 
F). Since glucose intolerance is often linked to disturbed 
insulin signaling in the liver, we measured a marker of tis-
sue insulin resistance, i.e., the inhibitory phosphorylation 
of IRS1 at  Ser307. High-fructose diet increased the hepatic 
level of  Ser307 IRS1 phosphorylation in both fructose and 
fructose + stress groups (by 25 and 29%, respectively) with 
respect to untreated controls (Fig. 2b, p < 0.05, F vs. C, SF 
vs. C), pointing to impaired hepatic insulin signaling. Sim-
ilarly, the hepatic level of phospho  Ser307 IRS1 protein was 
increased by 40% in the fructose + stress group compared 
to stressed animals, which emphasizes the effect of fruc-
tose on the inhibitory phosphorylation of IRS1 (Fig. 2b, 
p < 0.01, SF vs. S). Stress alone did not affect the level of 
phospho  Ser307 IRS1 protein.
Plasma triglycerides were significantly increased by fruc-
tose diet in both groups as compared to the control animals 
(Table 2, p < 0.001, F vs. C, p < 0.05, SF vs. C) and decreased 
in fructose + stress group in comparison to fructose-fed ani-
mals (p < 0.05, SF vs. F). The fatty acid profile of total plasma 
lipids demonstrated increased palmitic acid (16:0) in both 
fructose-fed groups compared to untreated control; still, this 
increase was more prominent in the fructose + stress group 
(Table 2, p < 0.05, F vs. C; p < 0.01, SF vs. C). Liver tri-
glycerides were not changed in any of the examined groups, 
although stressed animals demonstrated slightly decreased 
hepatic lipids as compared to the control or fructose-fed rats 
(Table 2). This result was confirmed by histological analysis, 
which demonstrated that dietary fructose and/or stress treat-
ment did not cause pathological changes or lipid accumula-
tion in the liver (Fig. 3). Fatty acid profile of hepatic lipids 
revealed significantly increased palmitic, oleic acid (18:1n-9) 
and monounsaturated fatty acids (MUFA) by fructose diet, 
irrespective of stress, while PUFA was decreased with fructose 
diet (Table 2, palmitic acid: p < 0.001, F vs. C; SF vs. C; oleic 
acid: p < 0.05, F vs. C; p < 0.01, SF vs. C; MUFA, p < 0.05, F 
vs. C, p < 0.05, SF vs. S; PUFA, p < 0.001, F vs. C, SF vs. C). 
On the other hand, stearic acid (18:0) was not changed, result-
ing in increased hepatic Δ9 desaturase index in both fructose-
fed groups (Table 2, p < 0.05, F vs. C; p < 0.01, SF vs. C).
Hepatic inflammation is induced by high‑fructose 
diet
Fructose intake increased the hepatic level of proinflam-
matory cytokines TNFα and IL-1β by 45−55% in the 
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Fig. 1  Effect of high-fructose diet and/or chronic stress on GR and 
PEPCK mRNA levels in the liver. Relative quantification of GR 
and PEPCK mRNA levels in the liver was done relative to amount 
of β-actin mRNA. Values are means ± SEM and are presented as fold 
of control (n = 6 rats per group). Comparisons between groups were 
made by two-way ANOVA followed by post hoc Tukey test. Two-way 
ANOVA demonstrated the significant effect of fructose diet on the 
PEPCK mRNA (p < 0.001). Asterisk indicates significant difference 
with respect to the control (*p < 0.05). Control untreated (C), fruc-
tose-fed (F), stressed (S) and fructose-fed stressed (SF) rats
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fructose-fed group in comparison to untreated control ani-
mals (Table 3, p < 0.05, F vs. C, for both TNFα and IL-1β). 
Similarly, TNFα and IL-1β were increased by 54−60% in 
the fructose + stress group as compared to the stress group 
(Table 3, p < 0.05, SF vs. S, for both cytokines). Stress gen-
erally tended to decrease by ~ 20% the hepatic protein levels 
of TNFα and IL-1β in the fructose + stress group compared 
to fructose-fed animals, although this trend did not reach 
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Fig. 2  Effect of high-fructose diet and chronic stress on the indica-
tors of glucose homeostasis [intraperitoneal glucose tolerance test 
(IPGT) and inhibitory  Ser307 phosphorylation of IRS1 (phospho-
Ser307 IRS1)]. a IPGTT was done in male Wistar rats after overnight 
fasting. The intraperitoneal injection of glucose (2 g/kg) was admin-
istered and glucose concentration was determined in the blood drawn 
from the tail vein before glucose injection and 15, 30, 60, 90, and 
120  min after the injection. Each experimental point represents the 
mean ± SEM (n = 6 rats per group). b Representative Western blot 
and relative quantification of the phospho-Ser307 IRS1 in the whole 
cell extract of the liver of control untreated (C), fructose-fed (F), 
stressed (S) and fructose-fed stressed (SF) rats. Lower part of the blot 
was probed with antibody against β-actin that was used as a loading 
control. Values are means ± SEM and are presented as fold of con-
trol (n = 8–9). Comparisons between groups were made by two-way 
ANOVA followed by post hoc Tukey test. Two-way ANOVA dem-
onstrated the significant effect of fructose diet on the glucose peak 
level (p < 0.05) and on the level of phospho-Ser307 IRS1 (p < 0.001). 
Different symbols denote the values that are significantly different 
from control group (*p < 0.05) or stress group (##p < 0.01). Control 
untreated (C), fructose-fed (F), stressed (S) and fructose-fed stressed 
(SF) rats
Table 2  Triglyceride (TG) levels and fatty acid alterations in total plasma and hepatic lipids and estimated hepatic Δ9 desaturase activities in 
male Wistar rats
The data are presented as means ± SEM (n = 8). Fatty acid concentrations are expressed as % of totally detected fatty acids. Comparisons 
between groups were made by two-way ANOVA followed by post hoc Tukey test. Different symbols denote the values that are significantly dif-
ferent from control group (*p < 0.05, **p < 0.01, ***p < 0.001), fructose-fed group ($p < 0.05, $$$p < 0.001) and stressed group (#p < 0.05)
MUFA monounsaturated fatty acids, PUFA polyunsaturated fatty acids, NS non-significant
Fatty acid (%) Control Fructose Stress Fructose + stress Two-way ANOVA
Fructose Stress Fructose × stress
Plasma TG (mmol/L) 1.09 ± 0.07 1.94 ± 0.11*** 1.0 ± 0.06 1.55 ± 0.14*,$ < 0.001 < 0.05 NS
Liver TG (mg/g) 43.76 ± 5.94 42.11 ± 4.25 32.26 ± 4.12 31.54 ± 1.21 NS < 0.05 NS
Plasma palmitic acid (16:0) (%) 24.58 ± 0.38 26.13 ± 0.58* 23.15 ± 0.21 26.55 ± 0.24** < 0.001 NS < 0.001
Hepatic palmitic acid (16:0) (%) 19.52 ± 0.19 21.4 ± 0.4*** 18.61 ± 0,13 21.25 ± 0.3*** < 0.001 NS NS
Hepatic stearic acid (18:0) (%) 17.54 ± 0.49 16.54 ± 0.97 18.77 ± 0.49 15.43 ± 0.47 NS NS NS
Hepatic oleic acid (18:1n-9) (%) 5.85 ± 0.32 9.29 ± 1.16* 4.90 ± 0.21 10.41 ± 1.14** < 0.001 NS NS
MUFA (%) 9.11 ± 0.33 14.33 ± 1.55* 7.61 ± 0.26 12.84 ± 1.72# < 0.001 NS NS
PUFA (%) 54.78 ± 0.29 47.72 ± 1.04*** 55.2 ± 0.17 49.45 ± 0.97*** < 0.001 NS NS
Δ9 desaturase (18:1n-9/18:0) 0.33 ± 0.02 0.61 ± 0.11* 0.26 ± 0.01 0.69 ± 0.09** < 0.001 NS NS
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statistical significance (Table 3). As a result, TNFα and 
IL-1β protein levels, which were increased in the fructose-
only group compared to controls, were not significantly 
different in the fructose + stress group as compared to con-
trols (Table 3). A different pattern was observed for hepatic 
IL-6 protein that was increased only in fructose + stress 
Fig. 3  Histological analysis of the liver after high-fructose diet and chronic stress. Representative micrographs of hematoxylin–eosin-stained 
sections of hepatic tissue of control (C), fructose (F), stress (S) and stress + fructose (SF) groups of animals. Scale bar: 100 µm
Table 3  Cytokine concentrations in the liver after high-fructose diet and chronic stress
The levels of proinflammatory and anti-inflammatory cytokines in the hepatic whole cell extracts were determined by ELISA test
The data are presented as means ± SEM (n = 6–8). Comparisons between groups were made by two-way ANOVA followed by post hoc Tukey 
test. Different symbols denote the values that are significantly different from control group (*p < 0.05) or stress group (#p < 0.05, ###p < 0.001)
NS non-significant
Control Fructose Stress Fructose + stress Two-way ANOVA
Fructose Stress Fructose × stress
TNFα (pg/mg) 33.37 ± 3.38 51.52 ± 1.88* 26.82 ± 2.20 40.96 ± 5.11# < 0.001 < 0.05 NS
IL-1β (pg/mg) 85.53 ± 8.83 124.13 ± 6.72* 66.96 ± 5.35 107.54 ± 12.61# < 0.001 0.06 NS
IL-6 (pg/mg) 698.36 ± 50.37 888.18 ± 56.54 491.72 ± 32.03 1069.6 ± 120.6*,### < 0.001 NS < 0.05
IL-4 (pg/mg) 77.03 ± 8.18 94.91 ± 7.34 82.87 ± 5.19 99.68 ± 11.6 NS NS NS
IL-10 (pg/mg) 254.01 ± 20.68 247.55 ± 57.57 149.93 ± 14.5 311.64 ± 72.28 NS NS NS
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group in comparison to untreated controls and stress group 
(Table 3, p < 0.05, SF vs. C; p < 0.001, SF vs. S). Concentra-
tions of anti-inflammatory cytokines IL-4 and IL-10 were 
not significantly affected by any treatment (Table 3).
Proinflammatory protein NFκB is a key mediator of meta-
bolic inflammation in response to cytokine activation. Upon 
stimulation, the inhibitory protein IκB is phosphorylated and 
dissociates from NFκB, allowing its nuclear translocation. 
While the treatments had no effect on NFκB levels in the 
cytoplasmic fraction (Fig. 4a), fructose feeding increased 
the nuclear levels of NFκB by 30% in the liver of fructose-
fed unstressed rats in comparison to untreated control ani-
mals (Fig. 4a, p < 0.05, F vs. C). Interestingly, this response 
to fructose was moderately blunted by stress (− 23%) after 
combined treatment, as compared to fructose-fed animals, 
although this change was not statistically significant. Con-
sistent with these data, phosphorylated IκB cytoplasmic 
level was increased by ~ 20% upon high-fructose diet as 
compared to controls (Fig. 4b, p < 0.01, F vs. C; p < 0.05, 
SF vs. C), while total IκB was not changed. This resulted 
in the increased phospho-IκB/total IκB ratio only in the 
fructose-fed group (Fig. 4b, p < 0.01, F vs. C), an effect that 
was partially reduced by stress in the fructose + stress group 
(Fig. 4b, p < 0.05, SF vs. F).
Since both high-fructose diet and stress can modulate gut 
permeability and release of bacterial toxins into circulation, 
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Fig. 4  The subcellular distribution of NFκB and the levels of total 
IκB and IκB phosphorylation in the liver after high-fructose diet and/
or chronic stress. Representative Western blots and relative quan-
tification of NFκB protein level in cytoplasmic and nuclear fraction 
(a) and phospho-IκB and total IκB in the cytoplasmic fraction (b) of 
the liver of control untreated (C), fructose-fed (F), stressed (S) and 
fructose-fed stressed (SF) rats. Lower parts of the blots were probed 
with antibodies against β-actin and TATA-binding protein (TBP) that 
were used as loading controls for cytoplasmic and nuclear fraction, 
respectively. Values are means ± SEM and are presented as fold of 
control (n = 8–9). Comparisons between groups were made by two-
way ANOVA followed by post hoc Tukey test. Two-way ANOVA 
indicated the main effect of fructose diet on NFκB nuclear level 
(p < 0.01), on the IκB phosphorylation (p < 0.01), as well as signifi-
cant interaction of fructose diet and stress on the IκB phosphorylation 
(p < 0.05). Different symbols denote the values that are significantly 
different from control group (*p < 0.05, **p < 0.01) or fructose-fed 
group ($p < 0.05)
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we examined the expression of liver inflammatory marker 
activated by bacterial toxins such as TLR4 and NLRP3. 
The results demonstrated increased TRL4 mRNA in both 
stressed groups (Fig. 5a, p < 0.01, S vs. C; SF vs. C), clearly 
pointing out the effects of stress on this receptor. The incre-
ment of TRL4 mRNA by 70% is also evident when fruc-
tose + stress group is compared to fructose-fed animals 
(Fig. 5a, p < 0.05, SF vs. F). On the other hand, NLRP3 
protein was not changed in any of the examined groups 
(Fig. 5b), which suggests that this mechanism is not involved 
in the fructose-induced hepatic inflammation.
Other important components in the regulation of both 
metabolic inflammation and insulin resistance in the liver are 
JNK1/2 and ERK kinases. The activity of JNK1 (as reflected 
by the ratio of phosphorylated p46 isoform at  Thr183/Tyr185 
and total JNK1) was increased by fructose feeding by 29% 
(Fig. 6a, p < 0.05, F vs. C). On the other hand, the level of 
ERK activity (as reflected by the ratio of phosphorylated 
ERK at  Thr202/Tyr204 and total ERK protein) was not altered 
by the treatments (Fig. 6b). Thus, fructose feeding promoted 
hepatic inflammation, an effect that was partially attenuated 
by stress.
Effects of high‑fructose diet and/or stress 
on the levels of energy sensors in the liver
To assess whether fructose feeding alters energy-sensing 
pathways in the liver, we measured activation indexes of 
hepatic AMPK, SIRT1 and PGC-1α signaling. In parallel 
with increased hepatic inflammation, fructose decreased 
the ratio of cytoplasmic phospho-Tyr172 AMPK/total 
AMPK by 23 and 29% in fructose and fructose + stress 
groups, respectively, compared to controls, suggesting a 
decrease in AMPK hepatic activity (Fig. 7a, p < 0.01, F 
vs. C; SF vs. C). Of note, the decreased phospho-AMPK/
total AMPK ratios in these groups were due to a significant 
increase of total AMPK protein (+ 40 and + 48%) (Fig. 7a, 
p < 0.01, F vs. C; SF vs. C, medium panel) rather than a 
decrease in phosphorylation (Fig. 7a, left panel). Stress 
treatment alone tended to decrease phospho-AMPK/total 
AMPK ratio, but this effect did not reach statistical sig-
nificance (Fig. 7a, p = 0.063, S vs. C). The increased total 
AMPK protein was not the result of altered gene expres-
sion since AMPK mRNA was not changed after applied 
treatments (Fig. 7b). In addition, SIRT1 protein expres-
sion was increased in the liver of unstressed fructose-fed 
animals as compared to untreated control group (Fig. 7c, 
p < 0.05, F vs. C). Although the same trend was observed 
in the fructose + stress group, the fructose effect was 
attenuated by stress and did not reach statistical differ-
ence compared to both control and stress groups. Further-
more, nuclear levels of PGC-1α were not affected by either 
dietary fructose and/or stress (Fig. 7d).
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Fig. 5  The levels of TLR4 mRNA and NLRP3 protein in the liver 
after high-fructose diet and chronic stress. Relative quantification 
of TLR4 mRNA (a) and NLRP3 protein (b) in the liver of control 
untreated (C), fructose-fed (F), stressed (S) and fructose-fed stressed 
(SF) rats was done relative to level of β-actin mRNA and protein, 
respectively. Values are means ± SEM and are presented as fold of 
control (n = 8–9). Comparisons between groups were made by two-
way ANOVA followed by post hoc Tukey test. Two-way ANOVA 
indicated the main effect of stress on the TLR4 mRNA (p < 0.001). 
Different symbols denote the values that are significantly different 
from control group (**p < 0.01) or fructose-fed group ($p < 0.05)
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Discussion
In this study, we demonstrated that high-fructose diet trig-
gered hepatic inflammation, characterized by the activation 
of NFκB and JNK signaling pathways and increased levels 
of proinflammatory cytokines TNFα and IL-1β. Fructose 
overload also resulted in hypertriglyceridemia, glucose intol-
erance and impaired hepatic insulin signaling, but without 
ectopic lipid accumulation in the liver. These metabolic per-
turbations were accompanied by decreased hepatic AMPK 
activity. On the other hand, when high-fructose diet was 
applied together with chronic unpredictable stress, hepatic 
inflammation was partially prevented and glucose tolerance 
was preserved, most likely due to anti-inflammatory effects 
of glucocorticoids in the liver.
Many studies have linked fructose overconsumption to 
the development of obesity and metabolic disorders [35]. In 
the present study, both fructose-fed groups had decreased 
solid food intake, but increased total energy intake com-
pared to the rats on standard chow diet. Fructose diet did 
not increase liver or body weight in any of examined groups. 
Namely, other studies showed that a longer exposure to 
high-fructose diet (above 20 weeks) is needed to induce 
weight gain [36]. Still, the liver-to-body weight ratio was 
increased in fructose-fed unstressed animals, which was 
not related to increased hepatic triglycerides. Moreover, 
histological analysis did not show ectopic accumulation of 
hepatic lipids or signs of hepatic steatosis in any of exam-
ined groups. Although fructose is referred to as lipogenic 
sugar, essential for the development of hepatic steatosis 
is higher fructose concentration [37] or prolonged treat-
ment (more than 10 weeks) [38]. Still, the results from the 
present study confirmed hypertriglyceridemia and altered 
hepatic fatty acids composition as metabolic hallmarks of 
fructose-enriched diet. Namely, hepatic fatty acid profile 
was characterized by a higher proportion of MUFA, lower 
proportion of PUFA and increased oleic/stearic acid ratio 
(Δ9 desaturase index), regardless of stress. These results are 
in accordance with other animal studies using high-fructose 
diet [39–41]. In addition, it was previously demonstrated that 
fructose-induced increase of MUFA and decrease of PUFA 
in the liver were not accompanied by lipid accumulation and 
hepatic steatosis [39, 40], but rather with increased secretion 
of triglycerides, as observed in the present study.
Chronic unpredictable stress increased plasma corticos-
terone in stressed rats, which points to the activation of HPA 
axis and normal physiological response to chronic stress 
[42]. Interestingly, when stress was combined with dietary 
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Fig. 6  The levels of JNK and ERK phosphorylation in the liver 
after high-fructose diet and chronic stress. Representative Western 
blots and relative quantification of phospho-JNK1 (p46 isoform)/
total JNK1 (a) and phospho-ERK/total ERK (b) ratio in the liver of 
control untreated (C), fructose-fed (F), stressed (S) and fructose-fed 
stressed (SF) rats. Lower parts of the blots were probed with antibod-
ies against β-actin as loading control for whole cell extract. Values 
are means ± SEM and are presented as fold of control (n = 8–9). Com-
parisons between groups were made by two-way ANOVA followed 
by post hoc Tukey test. Two-way ANOVA showed that high-fructose 
diet is the main factor affecting JNK1 activity (ratio of phospho-
JNK1 and total JNK1) (p < 0.01). Asterisk indicates significant differ-
ence with respect to the control (*p < 0.05)
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fructose, the stress-induced rise of plasma corticosterone 
was absent, most likely due to reduced central reactivity of 
HPA axis [43]. On the other hand, hepatic corticosterone 
was increased in both stress and fructose + stress groups, 
possibly as a result of enhanced glucocorticoid prereceptor 
metabolism induced by high-fructose diet [27]. This state 
did not affect GR gene expression, as revealed in this and our 
previous study, but rather led to activation and nuclear accu-
mulation of GR [44]. In addition, chronic stress per se did 
not alter glucose homeostasis, which is in line with previous 
reports that chronic mild stress has relatively modest effects 
on glucose homeostasis that occurs primarily at the begin-
ning of stress exposure [45]. On the other hand, fructose-fed 
unstressed animals displayed altered glucose homeostasis, 
as characterized by hypoglycemia, hyperinsulinemia and 
impaired glucose tolerance, as revealed by IPGTT. Other 
studies also demonstrated that high-fructose diet induces 
hyperinsulinemia, disturbs both glucose and insulin tol-
erance [46], evokes insulin resistance and delays glucose 
disappearance rate [47]. The observed hypoglycemia in the 
fructose-fed animals is most likely the result of decreased 
expression of key gluconeogenic enzyme PEPCK, which is 
in accordance with previous studies on fructose-fed rats [27, 
36]. Interestingly, in the fructose + stress group, the stress 
treatment prevented the fructose-induced glucose intoler-
ance, which is supported by previous research indicating 
that chronic variable stress (CVS) improves glucose toler-
ance in sucrose-fed rats [48]. Indeed, in that study, CVS 
induced beneficial effects not through changes in fasting 
glucose, insulin or corticosterone, but rather through a 
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Fig. 7  The level of total AMPK, AMPK phosphorylation, SIRT1 
and PGC-1α in the liver after high-fructose diet and chronic stress. 
Representative Western blots and relative quantification of phospho-
AMPK, total AMPK and phospho-AMPK/AMPK ratio in the cyto-
plasmic fraction (a), AMPK mRNA (b), SIRT1 (c) and PGC-1α 
protein levels in the nucleus (d) of the liver of control untreated (C), 
fructose-fed (F), stressed (S) and fructose-fed stressed (SF) rats. 
Relative quantification of proteins (a, c, d) and AMPK mRNA (b) 
levels were done relative to amount of β-actin protein and mRNA, 
respectively. Values are means ± SEM and are presented as fold of 
control (n = 8–9). Comparisons between groups were made by two-
way ANOVA followed by post hoc Tukey test. Two-way ANOVA 
revealed the effect of fructose diet on total AMPK (p < 0.001), on 
phospho-AMPK/total AMPK ratio (p < 0.01) and significant interac-
tion between fructose diet and stress on phospho-AMPK/total AMPK 
ratio (p < 0.05), as well as the main effect of fructose diet on SIRT1 
protein level (p < 0.01). Asterisks indicate significant difference with 
respect to the control (*p < 0.05, **p < 0.01)
European Journal of Nutrition 
1 3
faster stress-related glucose clearance [48]. Therefore, in 
our animal model, the high-fructose diet induced glucose 
intolerance and prediabetes, an effect that was prevented by 
the stress treatment.
Fructose diet increased hepatic levels of proinflammatory 
cytokines TNFα and IL-1β, while pro-inflammatory IL-6 
and anti-inflammatory cytokines IL-4 and IL-10 remained 
unchanged, consistent with hepatic inflammation [49, 50]. 
The increased hepatic cytokine levels could be mediated 
by proinflammatory NFκB and JNK signaling pathways 
in the liver [51]. Indeed, consistent with previous reports 
[52], fructose consumption increased both the hepatic NFκB 
signaling, as indicated by IκBα phosphorylation and NFκB 
nuclear translocation, and JNK signaling, as revealed by the 
increase in the phospho-JNK1 to total JNK1 ratio. Consist-
ent with the fact that NFκB and JNK signaling have been 
implicated in insulin resistance, fructose feeding increased 
the inhibitory phosphorylation of IRS1 on the  Ser307, which 
represents an early hallmark of tissue insulin resistance [51]. 
On the other hand, hepatic ERK signaling pathway, which 
also regulates insulin sensitivity through inhibitory phos-
phorylation of IRS1 on  Ser612 [6], was not changed in these 
animals. Therefore, high-fructose diet induced the vicious 
cycle comprised of hepatic inflammation, decreased hepatic 
insulin sensitivity and glucose intolerance [53].
It is not fully understood how excess nutrients are sensed 
within the cells and how they promote the inflammatory 
program in the context of high-fructose diet. Several stud-
ies have revealed a close link between metabolic inflam-
mation and reduced AMPK activity, e.g., in adipose tissue 
and heart [11, 54], and few studies have investigated the 
relationship between fructose-induced inflammation and 
AMPK signaling pathway. In our study, high-fructose diet 
diminished hepatic AMPK activity, represented as decreased 
phospho-AMPK/AMPK ratio [55]. In agreement with the 
results obtained by Chen et  al. [56], high-fructose diet 
increased total AMPK level without significantly affecting 
phospho-AMPK. Several mechanisms could account for the 
observed effects of fructose diet on the AMPK activity. Pre-
vious study demonstrated that elevated insulin can signifi-
cantly increase total AMPKα protein level without affecting 
AMPK phosphorylation level [57], which is in accordance 
with the results obtained in the present study. In addition, 
according to study by Beauloye et al. [58], inhibitory effect 
of insulin on AMPK protein is reflected in its decreased 
activity. However, in our study, the observed phenomenon 
was not related to the altered expression of AMPK gene, 
but possibly to AMPK phosphorylation at  Ser485 driven by 
insulin-induced Akt, which reduces  Thr172 phosphorylation 
and inhibits AMPK activation [58]. Furthermore, high-fruc-
tose diet, via the increase in methylglyoxal production, could 
provoke carbonyl stress on AMP binding sites in AMPK, 
thus irreversibly blocking the phosphorylation of AMPK on 
 Thr172 and its activation [59]. It is conceivable that fructose-
induced hepatic inflammation through the stimulation of the 
NFκB signaling pathway is facilitated by decreased AMPK 
activity, as observed in the fructose-fed group [16]. This 
hypothesis is supported by prior findings that consumption 
of 30% fructose solution leads concomitantly to increased 
pro-inflammatory cytokines and decreased phospho-AMPK/
AMPK ratio in the rat liver [56] and that fructose-induced 
inflammation and NFκB activation in the diabetic murine 
heart is causally related to reduced AMPK activity [12]. The 
suggested role of AMPK as an important energy sensor link-
ing fructose metabolism to the regulation of inflammatory 
signaling is further supported by recent findings of Cao et al. 
[60], showing that fructose amplifies inflammatory potential 
in human monocytic cells via a reduction of AMPK activity. 
However, high fructose concentrations in the liquid form 
can affect gut permeability, leading to the leakage of bacte-
ria and their endotoxins into the circulation [61]. Therefore, 
metabolic effects of fructose on hepatic inflammation may 
not be direct but then conducted through the toxic effects of 
bacterial products on the liver cells, especially through acti-
vation of TLR4 [62] and NLRP3 inflammasome [63]. How-
ever, in the present study, both TRL4 mRNA and NLRP3 
protein were unchanged in the fructose-fed group, suggest-
ing that this mechanism was not involved in the observed 
fructose-induced hepatic inflammation. Interestingly, the 
results clearly showed the effect of stress on TRL4 mRNA, 
which was increased in all stressed rats independently of 
fructose diet. This could be a consequence of increased 
saturated palmitic and oleic fatty acids in the plasma lipids 
of fructose + stress group, observed in this and our previ-
ous study [64], which can act as endogenous TLR4 ligands 
in hepatic cells [65]. However, this was not accompanied 
with increased NLRP3 protein or activated NFκB signal-
ing pathway. Consequently, stress treatment alone did not 
change any of the monitored cytokines and did not alter the 
expression of proinflammatory kinases as compared to the 
control group. Namely, chronic restraint stress  could pro-
mote immune suppression through activation of TLR4 and 
subsequent modulation of phosphoinositide 3-kinase (PI3K)/
Akt signaling   [66]. Therefore, after combined treatment 
stress generally tended to decrease the expression of pro-
inflammatory cytokines, although a significant protective 
effect was observed only for TNFα and IL-1β proteins in 
the proinflammatory context of fructose feeding in the fruc-
tose + stress group. On the contrary, the combined treatment 
increased only IL-6 levels while did not affect anti-inflam-
matory cytokines (IL-4, IL-10). This is overall in agreement 
with previous finding that chronic psychological stress miti-
gates the effects of high-fructose–high-fat diet on hepatic 
inflammation [22], by promoting an adaptive anti-inflamma-
tory response. This effect of stress most likely results from 
the observed increase in hepatic corticosterone that generally 
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inhibits inflammation. However, consistent with our results, 
corticosterone can stimulate the synthesis and production 
of IL-6 through prolonged activation of signal transducer 
and activator of transcription 3 (STAT3) [67]. The increased 
IL-6 levels could account for the increased inhibitory IRS1 
 Ser307 phosphorylation in the group subjected to combined 
treatment, in the absence of JNK1 activation and probably 
through the Janus kinase (JAK)/STAT pathway [68]. Nev-
ertheless, in spite of signs of hepatic insulin resistance, ani-
mals in the fructose + stress group demonstrated preserved 
glucose tolerance, which implies dissociation of these two 
events and involvement of other insulin-sensitive tissues, 
like muscle or adipose tissue, in the regulation of glucose 
metabolism [69].
Intriguingly, although AMPK activation is reduced in 
both fructose groups regardless of stress, it is not followed 
by increased inflammation and activation of NFκB pathway 
after combined treatment. This is most likely an outcome 
of increased level of corticosterone and its anti-inflamma-
tory activity in the liver of these animals, which through 
decreased phospho-IκB/IκB ratio could directly inhibit the 
NFκB signaling pathway [70].
There are multiple mechanisms by which AMPK may 
alter NFκB activity, including AMPK-downstream regu-
lators such as SIRT1, PGC-1α and forkhead box protein 
O1 (FoxO1) [16]. However, SIRT1 and PGC-1α were not 
decreased with high-fructose diet in our study, and hence 
could not be considered as mediators of fructose-induced 
inflammation. Another possible mechanism for increased 
inflammation may be a decreased phosphorylation of 
FoxO1 and a consequent stimulation of inflammation [71]. 
This hypothesis is supported by previous reports that high-
fructose diet leads to increased nuclear FoxO1 in the rat 
and hamster liver [72], while augmented FoxO1 expression 
potentiates pro-inflammatory cytokine production in the 
liver of diabetic mice [71].
In summary, this study suggests that high-fructose diet 
resulted in decreased AMPK activity, induced hepatic 
inflammation, impaired glucose tolerance and hepatic 
insulin signaling, without concomitant lipid accumulation 
or hepatic steatosis. Chronic stress alone had no effect on 
AMPK activity, hepatic inflammation and insulin sensitiv-
ity. Chronic stress combined with a high-fructose diet did 
not prevent fructose-induced suppression of AMPK activ-
ity but could restore glucose tolerance and partially prevent 
development of hepatic inflammation. Future studies are 
warranted to determine the exact role of AMPK in fructose-
induced hepatic inflammation.
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